Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIVOLUMAB vs NORTRIPTYLINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIVOLUMAB vs NORTRIPTYLINE: Safety Overview

Metric NIVOLUMAB NORTRIPTYLINE
Total FAERS Reports 87,742 6,073
Deaths Reported 23,086 1,810
Death Rate 26.3% 29.8%
Hospitalizations 36,530 1,398
Average Patient Age 64.2 yrs 50.6 yrs
% Female Patients 34.0% 72.4%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer E.R. Squibb & Sons, L.L.C. Northwind Health Company, LLC
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued